2.98
price up icon3.11%   0.09
after-market Handel nachbörslich: 3.00 0.02 +0.67%
loading

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
7.34%
11.85
11.04 10.70 12.14 9.732
Operating Income/Loss
7.34%
-11.85
-11.04 -10.70 -12.14 -9.732
Nonoperating Income/Loss
7.80%
0.756
0.82 0.84 0.846 0.687
Income/Loss From Continuing Operations Before Tax
53.72%
-11.10
-23.97 -9.86 -11.29 -9.045
Income/Loss From Continuing Operations After Tax
8.55%
-11.10
-10.22 -9.86 -11.29 -9.045
Net Income/Loss
8.55%
-11.10
-10.22 -9.86 -11.29 -9.045
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.87K%
11.42
0.0113 11.35 11.31 11.30
Diluted Average Shares
100.87K%
11.42
0.0113 11.35 11.31 11.30
Basic Earnings Per Share
7.78%
-0.97
-0.90 -0.87 -1.00 -0.80
Diluted Earnings Per Share
7.78%
-0.97
-0.90 -0.87 -1.00 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.73
price up icon 1.02%
$35.27
price down icon 1.78%
$21.32
price up icon 0.24%
$101.74
price down icon 2.97%
$106.14
price up icon 1.28%
biotechnology ONC
$254.49
price down icon 4.73%
Kapitalisierung:     |  Volumen (24h):